Technology
Samsung drug-making unit soars on market debut
10 years agoThe firm was set up by the South Korean conglomerate in 2011 as part of a multi-billion-dollar drive to find new growth avenues. PHOTO: SAMSUNG BIOLOGICS
Shares in Samsung's drug-making unit soared almost six percent on their market debut Thursday, after one of South Korea's biggest ever initial public offerings that raised nearly $2 billion.